A peptide
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Product Categories

RGD-targeted Proapoptotic Peptide

Item No. 42136

Technical Information
Formal Name
L-alanyl-L-cysteinyl-L-a-aspartyl-L-cysteinyl-L-arginylglycyl-L-a-aspartyl-L-cysteinyl-L-phenylalanyl-L-cysteinylglycylglycyl-D-lysyl-D-leucyl-L-alanyl-D-lysyl-D-leucyl-D-alanyl-D-lysyl-D-lysyl-D-leucyl-D-alanyl-D-lysyl-D-leucyl-D-alanyl-D-lysine, cyclic (2→10),(4→8)-bis(disulfide)
CAS Number
2243207-09-0
Molecular Formula
C116H199N35O31S4
Formula Weight
Purity
≥95%
A solid
Peptide Sequence
A-cyclo[CD-cyclo[CRGDC]FC]GGklAklAkklaklak-OH
Acetonitrile: Slightly Soluble: 0.1-1 mg/mLWater: Slightly Soluble: 0.1-1 mg/mL
SMILES
C[C@@H](C(N[C@@H](CSSC[C@H](N1)C(NCC(NCC(N[C@@H](CCCCN[H])C(N[C@H](C(N[C@H](C(N[C@@H](CCCCN[H])C(N[C@H](C(N[C@H](C(N[C@@H](CCCCN[H])C(N[C@@H](CCCCN[H])C(N[C@H](C(N[C@H](C(N[C@@H](CCCCN[H])C(N[C@H](C(N[C@H](C(N[C@@H](CCCCN[H])C(O)=O)=O)C)=O)CC(C)C)=O)=O)C)=O)CC(C)C)=O)=O)=O)C)=O)CC(C)C)=O)=O)C)=O)CC(C)C)=O)=O)=O)=O)C(N[C@@H](CC(O)=O)C(N[C@@H](CSSC[C@H](N2)C(N[C@H](C1=O)CC3=CC=CC=C3)=O)C(N[C@@H](CCC/N=C(N[H])/N)C(NCC(N[C@@H](CC(O)=O)C2=O)=O)=O)=O)=O)=O)=O)N[H]
InChi Code
InChI=1S/C116H199N35O31S4/c1-60(2)46-77(105(171)130-66(11)95(161)137-73(34-19-25-41-119)102(168)143-78(47-61(3)4)106(172)131-65(10)94(160)136-72(33-18-24-40-118)101(167)140-75(36-21-27-43-121)104(170)145-80(49-63(7)8)107(173)132-67(12)96(162)138-74(35-20-26-42-120)103(169)144-79(48-62(5)6)108(174)133-68(13)97(163)141-76(115(181)182)37-22-28-44-122)142-100(166)71(32-17-23-39-117)134-89(153)54-127-88(152)53-128-99(165)84-56-183-184-57-85(148-93(159)64(9)123)113(179)147-83(52-92(157)158)111(177)151-86-58-185-186-59-87(114(180)146-81(109(175)149-84)50-69-30-15-14-16-31-69)150-110(176)82(51-91(155)156)135-90(154)55-129-98(164)70(139-112(86)178)38-29-45-126-116(124)125/h14-16,30-31,60-68,70-87H,17-29,32-59,117-123H2,1-13H3,(H,127,152)(H,128,165)(H,129,164)(H,130,171)(H,131,172)(H,132,173)(H,133,174)(H,134,153)(H,135,154)(H,136,160)(H,137,161)(H,138,162)(H,139,178)(H,140,167)(H,141,163)(H,142,166)(H,143,168)(H,144,169)(H,145,170)(H,146,180)(H,147,179)(H,148,159)(H,149,175)(H,150,176)(H,151,177)(H,155,156)(H,157,158)(H,181,182)(H4,124,125,126)/t64-,65-,66-,67-,68-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-/m0/s1
InChi Key
NEUVHFXXJASAGM-UUIRIWLISA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    RGD-targeted proapoptotic peptide is a peptide that contains an integrin-binding cyclic region (CDCRGDCFC) and a region similar to a pro-apoptotic heptadimer sequence (klaklakklaklak), both of which are found in similar peptides.1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Gerlag, D.M., Borges, E., Tak, P.P., et alSuppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature. Arthritis Res. 3(6), 357-361 (2001).